about
Advances in targeting signal transduction pathwaysMacrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitusVersatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo.Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyMutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.Targeting the cancer initiating cell: the ultimate target for cancer therapy.Resistance to TRAIL and how to surmount it.Antiproliferative activity of (η(6)-arene)ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines.Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines.Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy.Extracellular iron diminishes anticancer effects of vitamin C: an in vitro study.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations.Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.Cell-type dependent response of melanoma cells to aloe emodin.Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells.Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells.Multiple antimelanoma potential of dry olive leaf extract.Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO.Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo.The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo.Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study.Aloe emodin inhibits the cytotoxic action of tumor necrosis factor.
P50
Q27686983-A2FFF08A-0419-4B3D-B542-3F084FEF5B82Q28260247-F92CD075-4D55-49F6-8EAF-5B0D2FAE7810Q30315742-AA6F802D-AB37-4E6B-856E-FB055A26044FQ30316001-028FBECE-6C76-40AF-ABAA-24B87925E9EBQ32061593-7490A9F5-E2DC-4687-9926-6953463BC02DQ34103963-8F88B7BC-EFA6-4D2E-9413-CEDDF53C5CB9Q34179539-44600D2F-2F22-4DC8-AEE1-7FE86A9A833FQ34307356-BA364D25-390E-4189-802F-52DB4627A225Q34966603-9228A036-9C06-4F78-8A1B-BC3FCF940BF7Q34979356-C57F4805-2836-47FF-A457-EB70CBC099F5Q35679353-64646561-0B35-47C2-9183-2673F1DFA54AQ36107216-001C68AA-2023-45F4-A9FF-36959C7F09DEQ36862768-0FFE222C-F473-46D9-941F-3DB41DE671DDQ37837732-317125E9-81F2-4250-9E53-FC7416D1732CQ37990970-C311C17E-8956-4A5A-B01D-FB696E999383Q37992546-20D80537-41B0-41C9-8E02-AC777C2D199CQ38695135-1EBD6312-F6C9-4B09-81AB-67A6D91220D1Q38746895-FA92BB63-8D1F-41EB-ABFD-7A14B8B1EFDAQ38762743-68A40B26-2A73-44E5-9E3F-BF68B0F9BECCQ38968714-35B788BF-BC63-4D6F-A005-B6A196D887A8Q39015233-DD742CC1-C557-4EC4-B858-F1F5EA54B5F2Q39029785-08E5A54B-38DD-4DF3-AFCC-F68C90837E0BQ39094988-3A1B6EF5-CB52-4446-A1E4-679A5638EB3BQ39192985-885C7F86-AD85-4A64-943E-9E75B56F2DEAQ39270889-E47AB10F-6A59-4DA4-A5F1-D4F5587973B4Q39310363-B2D6308C-8080-4274-BA8E-F6DED0FA86F8Q39313996-EE686F8B-2430-4923-BF33-51348F6C3B69Q39334351-857B3C3D-C13C-4939-A019-B450940561FDQ39337196-EB8311EB-8902-4A9F-9D7D-623CAD81E3FBQ39389293-4347B620-AFBC-4791-AB91-CB8872D6840AQ39389516-A6D3FABC-ABC3-4763-90A8-DE3E61508F26Q39602151-4A2CA4B7-C818-4CF4-B633-E322D569ACCEQ39689891-DD0FD1C7-C396-48B8-B3A6-3F5A6CAD17D5Q39746181-58274972-51F5-4F57-822A-C2923BCF9DC0Q39786058-A078A98E-7464-481D-BF43-526A97B6D328Q39850762-8B1E6D88-145D-4DB0-BACE-1AB17D7168B2Q39984965-45037F7E-44B2-40A8-942F-CF8625F40F88Q40001479-CD6907E2-6B34-4153-B684-8F543637A5DBQ40007071-F6EDFE3B-29E1-4AEB-9F7A-F7B4625764E8Q40127457-5A374BFB-5A2B-446E-850D-BD735418D239
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Danijela Maksimović-Ivanić
@ast
Danijela Maksimović-Ivanić
@en
Danijela Maksimović-Ivanić
@es
Danijela Maksimović-Ivanić
@nl
Danijela Maksimović-Ivanić
@sl
type
label
Danijela Maksimović-Ivanić
@ast
Danijela Maksimović-Ivanić
@en
Danijela Maksimović-Ivanić
@es
Danijela Maksimović-Ivanić
@nl
Danijela Maksimović-Ivanić
@sl
altLabel
D Maksimovic-Ivanic
@en
D Maksimović-Ivanić
@en
D. Maksimovic-Ivanic
@en
D. Maksimović-Ivanić
@en
Danijela Maksimovic-Ivanic
@en
Maksimovic-Ivanic D
@en
Maksimovic-Ivanic D.
@en
Maksimovic-Ivanic
@en
Maksimović-Ivanić D
@en
Maksimović-Ivanić D.
@en
prefLabel
Danijela Maksimović-Ivanić
@ast
Danijela Maksimović-Ivanić
@en
Danijela Maksimović-Ivanić
@es
Danijela Maksimović-Ivanić
@nl
Danijela Maksimović-Ivanić
@sl
P1053
E-7246-2015
P106
P1153
6507584634
P21
P31
P3829
P496
0000-0002-8006-5079